strong organ growth price move right direct
ep came ahead street expect larg lower tax
still report strong organ top line growth broad-bas across
segment particularli electron keep cyclic
peer acceler macro environ price y/i slightli
estimate acceler flat think good enough
particularli given strong asia/pacif growth organ growth price
improv key concern sell-sid bear go quarter
healthi result posit stock reiter buy po
slight op miss driven corp/industri off-set tax
report adj ep beat estim
consensu driven lower tax compani pre-announce rang
decemb analyst meet rel model tax beat top line
strong organ growth come ahead forecast overal
segment op miss driven higher corpor cost headwind
includ legal charg industri miss weaker margin vs
estimate partial off-set beat post strong top
line organ growth vs estimate margin vs estimate safeti
 graphic consum beat vs model higher interest
expens headwind highlight strateg invest
quarter increment y/i
outlook rais lower tax
rais ep outlook come
estimate street new guidanc reflect lower tax rate
vs prior guidanc exclud net gain sale
commun market divis organ top-lin maintain
model rais dividend forecast like reflect
lower tax rate go forward maintain est may review model
net dbt
bear keep underestim busi
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
compani found mine
concern today minnesota-bas compani
diversifi global manufactur busi
technology-driven organ five
segment consum safeti graphic
electron health industri
popular brand includ scotch post-it
thinsul hold us patent
lower cyclic high-return portfolio
view posit investor current
compani well diversifi across end
market geographi
defens less cyclic busi model
focus shorter cycl product stock
defens tend outperform peer
market recess
chart revenu break-out segment
us mn except per share data
corpor unalloc
elimin dual credit
corpor unalloc
elimin dual credit
net incom attribut non-controlling interest
chart industri organ total y/i revenu growth
chart safeti graphic organ total y/i revenu growth
chart electron organ total y/i revenu growth
chart health organ total y/i revenu growth
chart consum organ total y/i revenu growth
chart total organ total y/i revenu growth
po base price-to-earnings line premium consum
good peer trade translat ev/ebitda growth
return characterist histor line high-qual consum
name industri cyclic believ trade
premium multi-industri peer line premium consum good peer
reflect superior growth return
downsid risk po compani larg global emerg market
exposur need greater invest could margin headwind slower-
andrew obin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us multi-industrials/engin construct coverag cluster
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
